The event is the industry’s preeminent event on novel drug targets and technologies for drug discovery professionals.

DOT highlights advances in current and emerging “hot” targets and technologies, as well as target validation strategies for the discovery and development of novel therapeutic agents, ranging from biologics to small molecules.